Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Updated ocular pharmacology for noninfectious uveitis: a comprehensive expert review.
Journal: Expert opinion on pharmacotherapy
Published: August 19, 2026
Phase 3 Randomized Clinical Trial Evaluating the Safety of Reproxalap in Patients With Dry Eye Disease.
Journal: Ophthalmology and therapy
Published: February 11, 2026
Comparing Global Operating Room Waste Generated From Cataract, Corneal, and Conjunctival Surgeries.
Journal: Cornea
Published: December 01, 2025
Ocular surface disease following LASIK and cataract surgery: a review of their interrelated complications.
Journal: Frontiers in medicine
Published: May 05, 2025
Reproxalap Improves Ocular Redness, Tear Production, and Symptoms in a Pivotal Dry Eye Disease Chamber Trial.
Journal: Ophthalmology science
Published: March 17, 2025
Corneal Staining Responder Analysis: A Clinically Meaningful Dry Eye Outcome.
Journal: Ophthalmology
Published: March 04, 2025
Impact of Neurostimulation, Immunomodulation, Topical Medication Application, and Surgical Reconstruction on Corneal Nerve Function and Regeneration.
Journal: Eye & contact lens
Published: August 19, 2024
Perfluorohexyloctane ophthalmic solution for dry eye disease: pooled analysis of two phase 3 clinical trials.
Journal: Frontiers in ophthalmology
Published: June 20, 2024
Pooled results from two pivotal randomized controlled clinical trials: ESSENCE-1 and ESSENCE-2 to assess efficacy and safety of a water-free ciclosporin 0.1% formulation for the treatment of dry eye disease.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: May 26, 2024
Tolerability of Current Treatments for Dry Eye Disease: A Review of Approved and Investigational Therapies.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: February 21, 2024
Efficacy of a new water-free topical cyclosporine 0.1% solution for optimizing the ocular surface in patients with dry eye and cataract.
Journal: Journal of cataract and refractive surgery
Published: December 15, 2023
A review of the first anti-evaporative prescription treatment for dry eye disease: perfluorohexyloctane ophthalmic solution.
Journal: The American journal of managed care
Published: November 06, 2023
Last Updated: 09/26/2026